Advertisement

Topics

20182023 United States Transdermal Drug Delivery System Market Report Status and Outlook [Report Updated: 07032018] Prices from USD $3360

18:49 EDT 12 Aug 2018 | BioPortfolio Report Blog

In 2017, the Transdermal Drug Delivery System market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.


In United States market, the top players include

Hisamitsu

Mylan

GSK

Novartis

Teve Actavis

Johnson Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum Company

Laboratoires Genevrier


Split by product types/category, covering

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other


Split by applications/end use industries, covers

OTC

Rx

Original Article: 20182023 United States Transdermal Drug Delivery System Market Report Status and Outlook [Report Updated: 07032018] Prices from USD $3360

NEXT ARTICLE

More From BioPortfolio on "20182023 United States Transdermal Drug Delivery System Market Report Status and Outlook [Report Updated: 07032018] Prices from USD $3360"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...